Abstract:Objective: Oxidative stress-induced retinal neurodegenerative changes are among the pathological alterations observed in diabetic retinopathy. Resveratrol (RSV), a polyphenolic compound with diverse pharmacological effects, has shown preventive qualities in several neurodegenerative illnesses, including anti-inflammatory, anti-aging, and antioxidant benefits. However, its therapeutic efficacy in diabetic retinal neurodegeneration has not yet been thoroughly elucidated. Our study aimed to explore the protective mechanisms and therapeutic benefits of RSV on diabetic retinal neurodegeneration alterations. Materials and methods: Using streptozotocin, we created a diabetic mouse model and conducted visual electrophysiological examinations on mice from the normal group, diabetic group, and diabetic group treated with RSV. Retinas were harvested for histological staining. Additionally, primary retinal ganglion cells cultured in high glucose conditions were used to assess malondialdehyde (MDA) levels and superoxide dismutase (SOD) levels upon siRNA-mediated nuclear factor erythroid 2-related factor 2 (Nrf2) interference. Protein levels of Nrf-2, heme oxygenase-1 (HO-1), and transcriptional levels of them were also measured. Results: We demonstrated that RSV significantly improved the retinal morphology and function in the diabetic retinopathy model mice. The treated mice exhibited notable improvements in visual electrophysiology, with a significant reduction in retinal ganglion cell apoptosis. Following RSV treatment, the high glucose-cultured ganglion cells demonstrated a considerable rise in SOD levels and a substantial drop in MOD. Moreover, the protein expression of solute carrier family 7 member 11 (SLC7A11) and Nrf2 significantly increased. RT-PCR and Western blot results indicated a significant attenuation of RSV's therapeutic effects upon Nrf2 inhibition. Conclusion: Our findings suggest that RSV may reduce oxidative stress levels in the retina and inhibit retinal ganglion cell apoptosis via reducing the Nrf2/HO-1 pathway, which lessens the harm that excessive glucose causes to the retina.

Resveratrol Prevention of Diabetic Nephropathy is Associated with the Suppression of Renal Inflammation and Mesangial Cell Proliferation: Possible Roles of Akt/NF-κB Pathway

Resveratrol Prevents Streptozotocin-Induced Diabetes by Inhibiting the Apoptosis of Pancreatic Β-Cell and the Cleavage of Poly (Adp-Ribose) Polymerase.

Resveratrol Ameliorates Early Diabetic Nephropathy Associated with Suppression of Augmented TGF-β/smad and ERK1/2 Signaling in Streptozotocin-Induced Diabetic Rats.

Resveratrol ameliorates diabetic nephropathy in rats through negative regulation of the p38 MAPK/TGF-β1 pathway

Resveratrol Inhibits High Glucose-Induced Activation of AP-1 and NF-κB Via SphK1/S1P2 Pathway to Attenuate Mesangial Cells Proliferation and Inflammation

Resveratrol Attenuates Early Diabetic Nephropathy by Down-Regulating Glutathione S-Transferases Mu in Diabetic Rats

Resveratrol Inhibits TNF-α-induced Inflammation to Protect Against Renal Ischemia/reperfusion Injury in Diabetic Rats.

Resveratrol prevents diabetic nephropathy by reducing chronic inflammation and improving the blood glucose memory effect in non-obese diabetic mice

Resveratrol Mitigates High-Fat Diet-Induced Vascular Dysfunction by Activating the Akt/eNOS/NO and Sirt1/ER Pathway

Resveratrol protects against diabetic retinal ganglion cell damage by activating the Nrf2 signaling pathway

Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK.

Resveratrol ameliorates podocyte damage in diabetic mice via SIRT1/PGC‐1α mediated attenuation of mitochondrial oxidative stress

Resveratrol protects mesangial cells under high glucose by regulating the miR-1231/IGF1/ERK pathway

Inhibitory Effect of Resveratrol on Advanced Glycation End Products-Induced Mesangial Cell Proliferation

Resveratrol ameliorates vasculopathy in STZ-induced diabetic rats: role of AGE-RAGE signalling.

High Glucose Induces Renal Mesangial Cell Proliferation and Fibronectin Expression Through JNK/NF-κB/NADPH Oxidase/ros Pathway, Which is Inhibited by Resveratrol

Protective Effect of Resveratrol on Kidney in Rats with Diabetic Nephropathy and Its Effect on Endoplasmic Reticulum Stress.

Resveratrol Modulates the Gut Microbiota and Inflammation to Protect Against Diabetic Nephropathy in Mice

Resveratrol Protects Against Renal Damage Via Attenuation of Inflammation and Oxidative Stress in High-Fat-Diet-Induced Obese Mice

RETRACTED ARTICLE: Resveratrol Rescues Hyperglycemia-Induced Endothelial Dysfunction Via Activation of Akt

Resveratrol Prevents Ros-Induced Apoptosis In High Glucose-Treated Retinal Capillary Endothelial Cells Via The Activation Of Ampk/Sirt1/Pgc-1 Alpha Pathway